(17078830), Q. X., (17078833), K. H., (17078836), X. M., (17078839), Y. W., (17078842), L. Z., (17078845), L. B., . . . (17078857), Q. C. (2025). Supplementary Table S1 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma.
शिकागो शैली (17वां संस्करण) प्रशस्ति पत्र(17078830), Qingsheng Xu, et al. Supplementary Table S1 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma. 2025.
एमएलए (9वां संस्करण) प्रशस्ति पत्र(17078830), Qingsheng Xu, et al. Supplementary Table S1 from Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma. 2025.
चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.